Literature DB >> 2163605

Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP).

R A Williamson1, F A Marston, S Angal, P Koklitis, M Panico, H R Morris, A F Carne, B J Smith, T J Harris, R B Freedman.   

Abstract

Disulphide bonds in human recombinant tissue inhibitor of metalloproteinases (TIMP) were assigned by resolving proteolytic digests of TIMP on reverse-phase h.p.l.c. and sequencing those peaks judged to contain disulphide bonds by virtue of a change in retention time on reduction. This procedure allowed the direct assignment of Cys-145-Cys-166 and the isolation of two other peptides containing two disulphide bonds each. Further peptide cleavage in conjunction with fast-atom-bombardment m.s. analysis permitted the assignments Cys-1-Cys-70, Cys-3-Cys-99, Cys-13-Cys-124 and Cys-127-Cys-174 from these peptides. The sixth bond Cys-132-Cys-137 was assigned by inference, as the native protein has no detectable free thiol groups.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2163605      PMCID: PMC1131427          DOI: 10.1042/bj2680267

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

1.  The amino acid sequence of Neurospora NADP-specific glutamate dehydrogenase. Peptides from digestion with a staphylococcal proteinase.

Authors:  J C Wootton; A J Baron; J R Fincham
Journal:  Biochem J       Date:  1975-09       Impact factor: 3.857

2.  Antibodies to major histocompatibility antigens produced by hybrid cell lines.

Authors:  G Galfre; S C Howe; C Milstein; G W Butcher; J C Howard
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

3.  Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors.

Authors:  G S Herron; M J Banda; E J Clark; J Gavrilovic; Z Werb
Journal:  J Biol Chem       Date:  1986-02-25       Impact factor: 5.157

4.  The 'knotting' problem in proteins. Loop penetration.

Authors:  M H Klapper; I Z Klapper
Journal:  Biochim Biophys Acta       Date:  1980-11-20

5.  Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases.

Authors:  Y Okada; S Watanabe; I Nakanishi; J Kishi; T Hayakawa; W Watorek; J Travis; H Nagase
Journal:  FEBS Lett       Date:  1988-02-29       Impact factor: 4.124

6.  An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases.

Authors:  G Murphy; T E Cawston; J J Reynolds
Journal:  Biochem J       Date:  1981-04-01       Impact factor: 3.857

7.  Purification of rabbit bone inhibitor of collagenase.

Authors:  T E Cawston; W A Galloway; E Mercer; G Murphy; J J Reynolds
Journal:  Biochem J       Date:  1981-04-01       Impact factor: 3.857

8.  Human skin fibroblast collagenase inhibitor. Purification and biochemical characterization.

Authors:  G P Stricklin; H G Welgus
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

9.  Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family.

Authors:  W G Stetler-Stevenson; H C Krutzsch; L A Liotta
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

10.  Tissue inhibitor of metalloproteinases (TIMP) regulates extracellular type I collagen degradation by chondrocytes and endothelial cells.

Authors:  J Gavrilovic; R M Hembry; J J Reynolds; G Murphy
Journal:  J Cell Sci       Date:  1987-03       Impact factor: 5.285

View more
  30 in total

1.  The NTR module: domains of netrins, secreted frizzled related proteins, and type I procollagen C-proteinase enhancer protein are homologous with tissue inhibitors of metalloproteases.

Authors:  L Bányai; L Patthy
Journal:  Protein Sci       Date:  1999-08       Impact factor: 6.725

2.  Clinical features of a novel TIMP-3 mutation causing Sorsby's fundus dystrophy: implications for disease mechanism.

Authors:  M Clarke; K W Mitchell; J Goodship; S McDonnell; M D Barker; I D Griffiths; N McKie
Journal:  Br J Ophthalmol       Date:  2001-12       Impact factor: 4.638

3.  Involvement of a region near valine-69 of tissue inhibitor of metalloproteinases (TIMP)-1 in the interaction with matrix metalloproteinase 3 (stromelysin 1).

Authors:  H Nagase; K Suzuki; T E Cawston; K Brew
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

4.  Purification of recombinant human prostromelysin. Studies on heat activation to give high-Mr and low-Mr active forms, and a comparison of recombinant with natural stromelysin activities.

Authors:  P A Koklitis; G Murphy; C Sutton; S Angal
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

5.  Peptide from the C-terminal domain of tissue inhibitor of matrix metalloproteinases-2 (TIMP-2) inhibits membrane activation of matrix metalloproteinase-2 (MMP-2).

Authors:  Xiaoping Xu; Margarita Mikhailova; Zhihua Chen; Sanjay Pal; Trista K Robichaud; Eileen M Lafer; Sam Baber; Bjorn Steffensen
Journal:  Matrix Biol       Date:  2011-08-04       Impact factor: 11.583

Review 6.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 7.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

Review 8.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

Review 9.  Progress in matrix metalloproteinase research.

Authors:  Gillian Murphy; Hideaki Nagase
Journal:  Mol Aspects Med       Date:  2008-05-24

Review 10.  The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.

Authors:  Keith Brew; Hideaki Nagase
Journal:  Biochim Biophys Acta       Date:  2010-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.